title: BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
abstract: Exposure of mammalian cells to genotoxic agents evokes a complex cellular response. An ordered series of molecular events is necessary to sense DNA damage, transduce the signal, and ultimately delay the cell cycle or trigger apoptosis. Recently, we have shown that BTG2/TIS21 gene expression was induced in response to DNA damage through a p53-dependent pathway. This gene belongs to a newly identified family of structurally related genes whose other known human members are BTG1, BTG3, and Tob. To define the respective involvement of these four related genes in the cellular response to DNA damage, we studied their expression in human cell lines after a variety of genotoxic treatments. Our results demonstrated that were BTG1, BTG2/TIS21, and Tob genes the DNA damage--inducible genes. However, BTG2/TIS21 appeared to be the only p53-transcriptional target gene. We speculate that BTG proteins may play a coordinate role in a general transduction pathway that is induced in response to DNA damage. It has been previously described that recombinant BTG1 and BTG2/TIS21 can physically interact with PRMT1, an arginine methyl transferase, suggesting that BTG1 and BTG2/TIS21 induction may lead to posttranslational modifications of cellular proteins. In support of this hypothesis, we showed that the endogenous induction of BTG1 and BTG2 after genotoxic treatment was correlated with a modulation of protein methylation.
authors.affiliation: INSERM U453 and Unité d'Oncologie Moléculaire, Centre Léon Bérard, Lyon, France.
authors.forename: U
authors.initials: U
authors.lastname: Cortes
authors.forename: C
authors.initials: C
authors.lastname: Moyret-Lalle
authors.forename: N
authors.initials: N
authors.lastname: Falette
authors.forename: C
authors.initials: C
authors.lastname: Duriez
authors.forename: F E
authors.initials: FE
authors.lastname: Ghissassi
authors.forename: C
authors.initials: C
authors.lastname: Barnas
authors.forename: A P
authors.initials: AP
authors.lastname: Morel
authors.forename: P
authors.initials: P
authors.lastname: Hainaut
authors.forename: J P
authors.initials: JP
authors.lastname: Magaud
authors.forename: A
authors.initials: A
authors.lastname: Puisieux
mesh_terms: D000818:Animals; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism / Q000528:radiation effects; D004249:DNA Damage / Q000235:genetics*; D005720:Gamma Rays; D005786:Gene Expression Regulation / Q000187:drug effects / Q000528:radiation effects; D016147:Genes, Tumor Suppressor / Q000187:drug effects / Q000235:genetics / Q000528:radiation effects; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics* / Q000378:metabolism / Q000528:radiation effects; D051379:Mice; D009363:Neoplasm Proteins / Q000235:genetics* / Q000378:metabolism / Q000528:radiation effects; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism / Q000528:radiation effects; D025521:Tumor Suppressor Proteins; D014466:Ultraviolet Rays
chemical_list: C489552:Btg1 protein, mouse; C489435:Btg2 protein, mouse; D018797:Cell Cycle Proteins; D017874:Immediate-Early Proteins; D009363:Neoplasm Proteins; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; C070114:BTG2 protein, human; C074086:BTG1 protein, human